Article
Increased Risk-Taking Behaviour and Brain-Derived Neurotrophic Factor Val66Met Polymorphism Correlates to Decreased Serum Brain-Derived Neurotrophic Factor Level in Heroin Users.
European addiction research - 1 Jan 2018
Roviš Darko, Černelič Bizjak Maša, Vasiljev Marchesi Vanja, Petelin Ana, Jenuš Tina, Vidic Suzana, Drevenšek Gorazd, Jenko Pražnikar Zala
Abstract excerpt
BACKGROUND: This study has examined the relationships and interactions between serum brain-derived neurotrophic factor (BDNF) levels, BDNF Val66Met polymorphism and self-reported risk-taking behaviour in individuals with a history of heroin use undergoing outpatient treatment in comparison to healthy individuals. METHODS: We enrolled 167 heroin users and 86 healthy subjects and examined serum BDNF levels,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.